Advanced search
Publication Cover
Leukemia & Lymphoma Volume 18, 1995 - Issue 5-6
Submit an article Journal homepage
24
Views
31
CrossRef citations to date
0
Altmetric
Original Article

Relative Roles of Natural Killer- and T Cell-Mediated Anti-Leukemia Effects in Chronic Myelogenous Leukemia Patients Treated with Interferon-α

Graham Pawelec Section for Transplantation Immunology and Immunohematology, University of Tübingen, Tubingen; The Medical and Natural Sciences Research Center of the University of Tubingen, Tübingen
,
Paul Da Silva Section for Transplantation Immunology and Immunohematology, University of Tübingen, Tubingen
,
Heiner Max The Medical and Natural Sciences Research Center of the University of Tubingen, Tübingen
,
Hubert Kalbacher The Medical and Natural Sciences Research Center of the University of Tubingen, Tübingen
,
Helmuth Schmidt Section for Transplantation Immunology and Immunohematology, University of Tübingen, Tubingen
,
Øystein Bruserud Department of Medicine, University Hospital, Bergen, Norway
,
Ullrich Zügel Department of Immunology, University of Ulm, Ulm, Germany
,
Wolfgang Baier Section for Transplantation Immunology and Immunohematology, University of Tübingen, Tubingen
,
Arnika Rehbein Section for Transplantation Immunology and Immunohematology, University of Tübingen, Tubingen
&
Heike Pohlat The Medical and Natural Sciences Research Center of the University of Tubingen, Tübingen
 show all
Pages 471-478 | Received 21 Sep 1994, Published online: 01 Jul 2009

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Leonid Volodin, Prakash Peddi, Amol Takalkar, Jill M. Comeau, Jaime L. Shahan & Gerhard C. Hildebrandt. (2013) Successful treatment of first and second recurrence of acute lymphoblastic leukemia after related allogeneic bone marrow transplant at unusual sites using single-dose vincristine followed by interferon-α2b and granulocyte-macrophage colony-stimulating factor. Leukemia & Lymphoma 54:5, pages 1107-1109.
Read now
Fabiola Attié de Castro, Patricia Vianna Bonini Palma, Fabiana Rossetto Morais, Belinda Pinto Simões, Paulo Villas-Boas Carvalho, Sebastião José Ismael, Carmen Passos Voltarelli & Júlio César Morais. (2003) Immunological Effects of Interferon-alpha on Chronic Myelogenous Leukemia. Leukemia & Lymphoma 44:12, pages 2061-2067.
Read now
Cyril Fauriat, Emanuela Marcenaro, Simona Sivori, Jérôme Rey, Jean-Albert Gastaut, Alessandro Moretta, Daniel Olive & Régis T. Costello. (2003) Natural Killer Cell-triggering Receptors in Patients with Acute Leukaemia. Leukemia & Lymphoma 44:10, pages 1683-1689.
Read now
Bryce A. Pierson & Jeffrey S. Miller. (1997) The Role of Autologous Natural Killer Cells in Chronic Myelogenous Leukemia. Leukemia & Lymphoma 27:5-6, pages 387-399.
Read now

Articles from other publishers (27)

Kyoko Ito & Keisuke Ito. (2021) Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia. Cancers 13:22, pages 5822.
Crossref
Hui Mu, Xiaojian Zhu, Hui Jia, Lu Zhou & Hong Liu. (2021) Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation. Frontiers in Oncology 11.
Crossref
Fabien Muselli, Jean-François Peyron & Didier Mary. (2019) Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia. International Journal of Molecular Sciences 20:22, pages 5616.
Crossref
Mattias Carlsten & Marcus Järås. (2019) Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells. Frontiers in Immunology 10.
Crossref
Mette Ilander, Can Hekim & Satu Mustjoki. (2014) Immunology and Immunotherapy of Chronic Myeloid Leukemia. Current Hematologic Malignancy Reports 9:1, pages 17-23.
Crossref
Mette Ilander, Anna Kreutzman, Peter Rohon, Teresa Melo, Edgar Faber, Kimmo Porkka, Jukka Vakkila & Satu Mustjoki. (2014) Enlarged Memory T-Cell Pool and Enhanced Th1-Type Responses in Chronic Myeloid Leukemia Patients Who Have Successfully Discontinued IFN-α Monotherapy. PLoS ONE 9:1, pages e87794.
Crossref
Shelly Inbar, Elad Neeman, Roi Avraham, Marganit Benish, Ella Rosenne & Shamgar Ben-Eliyahu. (2011) Do Stress Responses Promote Leukemia Progression? An Animal Study Suggesting a Role for Epinephrine and Prostaglandin-E2 through Reduced NK Activity. PLoS ONE 6:4, pages e19246.
Crossref
J.A. Campbell & L.N. Carayannopoulos. 2010. Comprehensive Toxicology. Comprehensive Toxicology 53 85 .
Valentina Nardi, Olaia Naveiras, Mohammad Azam & George Q. Daley. (2009) ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines. Blood 113:16, pages 3813-3820.
Crossref
Annette M Marleau, Jeffrey H Lipton, Neil H Riordan & Thomas E Ichim. (2007) Therapeutic use of Aldara™ in chronic myeloid leukemia. Journal of Translational Medicine 5:1.
Crossref
Roi Avraham, Shelly Inbar, Ella Rosenne & Shamgar Ben-Eliyahu. (2006) Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells. Cancer Immunology, Immunotherapy 55:11, pages 1348-1357.
Crossref
Morgan E. Wallace & Mark J. Smyth. (2005) The role of natural killer cells in tumor control—effectors and regulators of adaptive immunity. Springer Seminars in Immunopathology 27:1, pages 49-64.
Crossref
Mariapia A. Degli-Esposti & Mark J. Smyth. (2005) Close encounters of different kinds: Dendritic cells and NK cells take centre stage. Nature Reviews Immunology 5:2, pages 112-124.
Crossref
Régis T Costello, Cyril Fauriat, Simona Sivori, Emanuela Marcenaro & Daniel Olive. (2004) NK cells: innate immunity against hematological malignancies?. Trends in Immunology 25:6, pages 328-333.
Crossref
F.A. Castro, P.V.B. Palma, F.R. Morais & J.C. Voltarelli. (2004) Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after bone marrow transplantation. Brazilian Journal of Medical and Biological Research 37:2, pages 201-206.
Crossref
Takatsune Shimizu, Yoshitaka Miyakawa, Atsushi Oda, Masahiro Kizaki & Yasuo Ikeda. (2003) STI571-resistant KT-1 cells are sensitive to interferon-α accompanied by the loss of T-cell protein tyrosine phosphatase and prolonged phosphorylation of Stat1. Experimental Hematology 31:7, pages 601-608.
Crossref
Régis T. Costello, J. Rey, C. Fauriat, J.-A. Gastaut & D. Olive. (2003) New approaches in the immunotherapy of haematological malignancies. European Journal of Haematology 70:5, pages 333-345.
Crossref
Pierre Portales, Jacques Reynes, Régine Rouzier-Panis, Vincent Baillat, Jacques Clot & Pierre Corbeau. (2003) Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection. AIDS 17:4, pages 505-511.
Crossref
Pierre Portales, Jacques Reynes, Valérie Pinet, Régine Rouzier-Panis, Vincent Baillat, Jacques Clot & Pierre Corbeau. (2003) Interferon-α restores HIV-induced alteration of natural killer cell perforin expression in vivo. AIDS 17:4, pages 495-504.
Crossref
Itaru Kataoka, Katsuji Shinagawa, Yoshihiko Shiro, Shinichiro Okamoto, Reiko Watanabe, Takehiko Mori, Daisuke Ito & Mine Harada. (2002) Multiple sclerosis associated with interferon‐alpha therapy for chronic myelogenous leukemia. American Journal of Hematology 70:2, pages 149-153.
Crossref
Régis T. CostelloSimona SivoriEmanuela MarcenaroMarina Lafage-PochitaloffMarie-Joelle MozziconacciDenis RevironJean-Albert GastautDaniela PendeDaniel OliveAlessandro Moretta. (2002) Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia. Blood 99:10, pages 3661-3667.
Crossref
Ming DengGeorge Q. Daley. (2001) Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia. Blood 97:11, pages 3491-3497.
Crossref
Paul P. Trotta, Guido Antonelli, James Bausch, Bryan R. G. Williams, Robert J. Spiegel & Peter von Wussow. (2000) Approval Standards for Alfa Interferon Subtypes. Drug Information Journal 34:4, pages 1231-1246.
Crossref
Ulf-Henrik MellqvistMarkus HanssonMats BruneClaes DahlgrenSvante HermodssonKristoffer Hellstrand. (2000) Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine. Blood 96:5, pages 1961-1968.
Crossref
M Talpaz, X Qiu, K Cheng, JE Cortes, H Kantarjian & R Kurzrock. (2000) Autoantibodies to Abl and Bcr proteins. Leukemia 14:9, pages 1661-1666.
Crossref
Jeffrey S. Miller. (1998) INNOVATIVE THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA. Hematology/Oncology Clinics of North America 12:1, pages 173-206.
Crossref
Federico Garrido, Francisco Ruiz-Cabello, Teresa Cabrera, Juan J. Pérez-Villar, Miguel López-Botet, Maggie Duggan-Keen & Peter L. Stern. (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunology Today 18:2, pages 89-95.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.